authors
-
Leszek Jeromin
- Klinika Urologii Instytutu Chirurgii AM w Łodzi
Dyrektor Instytutu: doc. dr H. Zalech p.o.
Kierownik Kliniki: doc. dr hab. n. med. L. Jeromin
summary
- The author believes that serum testosterone concentration in patients With
- prostatic carcinoma treated hormonally is of decisive importance for reliable prog-
- nosis and for sufficiently early introduction of changes in the therapeutic sche-
- dule.
references
- Albin R. J., Gonder M. J., Saanes W. A.: Serum proteins in prostatic can
- cer. I. Relationship between clinical stage and level. J. Urol., 1973, 110, 238.
- Baranowska B.: Patofizjologia i leczenie zaburzeń hormonalnych w przeroście
- gruczołu krokowego. Endokry. Pol., 1978, 6, 544
- Bartsh W., Steins P., Becker
- H.: Hormone blood levels in patients with prostatic carcinoma and their relation
- to the type of carcinoma growth differentation. Eur. Urol., 1977, 3, 47.
- Boyns
- A. R., Cole E. N., Golder M. P., Denutra V., Harper M. E., Brownsey B., Cowleii T.,
- Jones G. E., Griffiths K.: Prolactin studies with the prostate. In prolactin and
- carcinogenesis Fourth Tenovus Workshop. Botjns A. R., Griffiths K. (Eds). Cardiff.
- 1972.
- Dawidowicz A.: Biomolekularne podstawy interakcji hormon ? komór
- ka. PZWL. Warszawa 1975.
- Deykin D., Balko C: Recent studies on the me-
- chanism of action of testoterone. N. Engl. J. Med., 1972, 287, 1284.
- Farns
- worth W. E.: Human prostatic dehydroepiandrosterone sulfate sulfatase. Steroids,
- 1973, 21, 647.
- Farnsworth W. E., Brown J. R.: Androgen of the human pro
- state. Endocrine Research Communications, 1976, 3, 105.
- Habib F. K., Lee I.
- R., Stitch S. R., Smith P. H.: Androgen levels in the plasma and prostatic tissues
- of patients with benign hypertrophy and carcinoma of the prostate. J. Endocr.,
- 1976, 71, 90.
- Hafiez A. A., Philpott J. E., Bartke A.: The role of prolactin
- in the regulation of testicular function: the effect of prolactin and luteinizing hor
- mone on 3-beta-hydroxysteroid dehydrogenase activity in the testes of mice and
- rats J Endocr., 1971, 50, 619.
- Hafiez A. A., Lloyd C. W., Bartke A.: The role of prolactin in the regu
- lation of testis function: the effects of eprolactin and luteinizing hormone on the
- plasma levels of testosterone and androstenidione in hypophysectomized rats. J.
- Endocr., 1972, 52, 327.
- Harper M. E., Peeling W. B., Cowley T., Browney B.
- G., Phillips M. E. A., Groom G., Fahmy D. R., Griffiths K.: Plasma steroid and
- protein hormone concentration in patients with prostatic carcinoma, before and
- during oestrogen therapy. Acta Endocr., 1976, 81, 409.
- Houghton A. L., Turner
- R., Cooper E. H.: Sex hormone binding globulin in carcinoma of the prostate. Brit.J. Urol., 1977, 49, 227.
- Kato T., Horton R.: Studies of testosterone binding globulin. J. Clin. Endocr., 1968, 28, 1160.
- Kuligowski M.: Rola globuliny wiążącej sterydy płciowe (SHBG) w przemianie testosteronu do 5- (3-dwuhydrotesto-steronu i androstendiolu w skórze okolicy nadłonowej u kobiet. Endokr. Pol., 1978, 3, 191.
- Lasnitzki I., Franklin H. R.: The influence of serum on uptake con-version and action of testosterone in rat prostate glands in organ culture. J. Endocr., 1972, 54, 333.
- Massa R., Stupnicka E., Kniewald Z., Martini L.: The trans-formation of testosterone into dihydrotestosterone by the brain and the anterior pituitary. J. Steroid Biochem., 1972, 3, 385.
- Pirke K. M., Doerr P., Sinter-mann R., Vogt H. J.: Age dependence of testoterone precurosors in plasma of normal adult males. Acta Endocr., 1977, 86, 415.
- Prout G. R., Kliman B., Dały J, J., Maclaughlin R. A.: Griffin P. P.: In vitro uptake of 3H testosterone and its conversion do dihydrotestosterone by prostatic carcinoma and other tissues. J. Urol., 1976, 116, 603.
- Rubin R. T., Gouin R. P., Lubin A., Poland R. E., Pirke K. M.: Nocturnal increase of plasma testosterone in men: relation to gonadtropins and prolactin. J. Clin. Endocr. Metab., 1975, 40, 1027.
- Rudd B. T., Duignan N. M., London D. R.: A rapid method for the measu-rement of sex hormone binding globulin capacity of sera. Clin. Chim. Acta, 1974, 55, 165.
- Slaunwhite W. R., Sandberg A. A., Jackson J. E., Staubitz W. J.: Effects of estrogen and HCG on androgen synthesis by human testes. J. Clin. Endocr. Metab., 1962, 22, 992.
- Szamatowicz M., Sipowicz I., Sala J.: Pojemność globuliny wiążącej sterydy płciowe (SHB6) w surowicy oraz wydalanie estrogenów z moczem w zaburzeniach miesiączkowych u dziewcząt. Endokr. Pol., 1979, 1, 89.
- Szukalski B., Taracha E.: Mechanizm działania hormonów płciowych ? aspekty patogenetyczne i diagnostyczne. Endokr. Pol., 1977, 28, 479.
- Trze-ciak W., Łukaszyk A., Filipiak B.: Rola białek wiążących estrogeny w kontroli hormonalnej spermatogenezy. Endokry. Pol., 1976, 27, 3.
- Wall J. R., Jarrett R. J., Zimmet P. Z., Bailes M., Ramage C. M.: Fali in plasma-testosterone levels in normal male subjects in response to an orał glucose load. Lancet, 1973, 5, 967.
- Vermeulen A.: New investigational possibilities in male endocrine hypogona-dism. Organorama 13, 1976, 3, 3.
- Voigt W., Castro A.: Androgen and androgen receptors in prostatic cancer. Endocrine Control in Neoplasia, Raven Press. New York, 1978.
- Yanaikara T., Troen P.: Studies of the human testis I. Biosynthetic pathweys for androgen formation in human testicular tissue in vitro. J. Clin. Endocrin. Metab., 1972, 34, 783.
- Zumoff B.: Plasma hormone con-centrations in human breast and prostate cancer. Endocrine Control in Neoplasia, Raven Press, New York, 1978.
|